CIAS
ESPR

CFS Investment Advisory Services’s Esperion Therapeutics ESPR Stock Holding History

CFS Investment Advisory Services’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$50.1K Hold
24,551
– – ﹤0.01% 351
2025
Q4 		$90.8K Hold
24,551
– – 0.01% 328
2025
Q3 		$66.5K Hold
24,551
– – ﹤0.01% 340
2025
Q2 		$24K Hold
24,551
– – ﹤0.01% 323
2025
Q1 		$35K Hold
24,551
– – ﹤0.01% 307
2024
Q4 		$54K Hold
24,551
– – ﹤0.01% 294
2024
Q3 		$41K Hold
24,551
– – ﹤0.01% 290
2024
Q2 		$55K Hold
24,551
– – ﹤0.01% 257
2024
Q1 		$66K Hold
24,551
– – 0.01% 157
2023
Q4 		$73K Hold
24,551
– – 0.01% 150
2023
Q3 		$24K Hold
24,551
– – ﹤0.01% 160
2023
Q2 		$34K Hold
24,551
– – ﹤0.01% 235
2023
Q1 		$39K Hold
24,551
– – 0.01% 136
2022
Q4 		$153K Buy
+24,551
New +$176K 0.03% 124

Other funds holding ESPR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return